# Post-License Safety Evaluation of Influenza Virus Vaccine

> **NCT02136017** · — · COMPLETED · sponsor: **Sichuan Center for Disease Control and Prevention** · enrollment: 400000 (actual)

## Conditions studied

- Influenza
- Adverse Drug Event

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02136017
- **Lead sponsor:** Sichuan Center for Disease Control and Prevention
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 400000 (ACTUAL)
- **Last updated:** 2014-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02136017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02136017, "Post-License Safety Evaluation of Influenza Virus Vaccine". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02136017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*